Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

The hype started when celebrities were rumored to be using drugs like Wegovy off-label for aesthetic weight loss. Cue the ...

GPs across England will, for the first time, be able to prescribe a new weight loss injection on the NHS from Monday, as the health service embarks on a significant mass rollout. The medication, ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years in adults with overweight or obesity who do not have diabetes, according ...

Tirzepatide, approved by the FDA in 2022, works by tapping into the body’s gut hormone pathways to enhance glucose control and drive dramatic weight loss—delivering results that outperformed ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide ...

This article highlights the first head-to-head study comparing two popular injectable weight-loss medications, semaglutide (Wegovy) and tirzepatide (Zepbound). Conducted by Weill Cornell Medicine ...

CHICAGO — In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according to new data from the SURMOUNT-1 study. As Healio previously ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the European Congress on Obesity (ECO) in Malaga, Spain, reveal that the drug ...

As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...